PREFRONTAL COGNITIVE DYSFUNCTION IS ASSOCIATED WITH SMOKING CESSATION FAILURE WITH NICOTINE PATCH AND BUPROPION TREATMENT IN SMOKERS WITH SCHIZOPHRENIA

被引：0
|
作者：
Moss, Taryn Gabrielle [1 ,2 ]
Sacco, K. A. [4 ,5 ]
Allen, T. M. [4 ]
Weinberger, A. H. [4 ,5 ]
Vessicchio, J. C. [4 ,5 ]
George, T. P. [1 ,3 ]
机构：
[1] Ctr Addict & Mental Hlth, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada
[4] Connecticut Mental Hlth Ctr, Program Res Smokers Mental Illness PRISM, New Haven, CT USA
[5] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
来源：
SCHIZOPHRENIA BULLETIN | 2009年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：302 / 303
页数：2
相关论文
共 50 条
  • [1] Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia
    Moss, Taryn G.
    Sacco, Kristi A.
    Allen, Taryn M.
    Weinberger, Andrea H.
    Vessicchio, Jennifer C.
    George, Tony P.
    DRUG AND ALCOHOL DEPENDENCE, 2009, 104 (1-2) : 94 - 99
  • [2] Bupropion and nicotine patch as smoking cessation aids in alcoholics
    Grant, Kathleen M.
    Kelley, Stephanie Sinclair
    Smith, Lynette M.
    Agrawal, Sangeeta
    Meyer, James R.
    Romberger, Debra J.
    ALCOHOL, 2007, 41 (05) : 381 - 391
  • [3] A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia
    George, Tony P.
    Vessicchio, Jennifer C.
    Sacco, Kristi A.
    Weinberger, Andrea H.
    Duclas, Melissa M.
    Allen, Taryn M.
    Creeden, Cerissa L.
    Potenza, Marc N.
    Feingold, Alan
    Jatlow, Peter I.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (11) : 1092 - 1096
  • [4] The nicotine patch and smoking reduction in smokers with schizophrenia
    Dalack, GW
    MeadorWoodruff, JH
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 397 - 397
  • [5] The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial
    Cinciripini, Paul M.
    Kypriotakis, George
    Green, Charles
    Lawrence, David
    Anthenelli, Robert M.
    Minnix, Jennifer
    Blalock, Janice A.
    Beneventi, Diane
    Morris, Chad
    Karam-Hage, Maher
    DEPRESSION AND ANXIETY, 2022, 39 (05) : 429 - 440
  • [6] A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
    Jorenby, DE
    Leischow, SJ
    Nides, MA
    Rennard, SI
    Johnston, JA
    Hughes, AR
    Smith, SS
    Muramoto, ML
    Daughton, DM
    Doan, K
    Fiore, MC
    Baker, TB
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (09): : 685 - 691
  • [7] Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia
    George, TP
    Ziedonis, DM
    Feingold, A
    Pepper, WT
    Satterburg, CA
    Winkel, J
    Rounsaville, BJ
    Kosten, TR
    AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (11): : 1835 - 1842
  • [8] Analyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers
    Shiffman, S
    Scharf, DA
    Shadel, WG
    Gwaltney, CJ
    Dang, QY
    Paton, SM
    Clark, DB
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2006, 74 (02) : 276 - 285
  • [9] The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia
    Chou, KR
    Chen, R
    Lee, JF
    Ku, CH
    Lu, RB
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2004, 41 (03) : 321 - 330
  • [10] Bupropion and cognitive-behavioral treatment for depression in smoking cessation
    Brown, Richard A.
    Niaura, Raymond
    Lloyd-Richardson, Elizabeth E.
    Strong, David R.
    Kahler, Christopher W.
    Abrantes, Ana M.
    Abrams, David
    Miller, Ivan W.
    NICOTINE & TOBACCO RESEARCH, 2007, 9 (07) : 721 - 730
12345